Traders looking ahead to the additional fiscal stimulus and other government spending
|Bid||0.0300 x 0|
|Ask||0.0350 x 0|
|Day's Range||0.0350 - 0.0350|
|52 Week Range||0.0100 - 0.0600|
|Beta (5Y Monthly)||-0.47|
|PE Ratio (TTM)||17.50|
|Earnings Date||Dec. 29, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
"Vencanna Ventures" (the "Company" or "Vencanna") (VENI.CN) (TPPRF) is pleased to announce the issuance of an Unsecured Convertible Debenture in the principal amount of US$1,300,000.00 (the "Debenture") to a private investment fund (the "Holder"). The Debenture matures on July 3, 2022 , with an interest rate of 8.0%, and is convertible at the option of the Holder into 26,000,000 common shares of the Company ("Shares"). The Company may, in its sole discretion, extend the maturity date an additional two years, in which case the interest rate shall be 9.2% and the Holder may convert the debenture at its option into 29,900,000 Shares.
VANCOUVER, BC, June 16, 2020 /CNW/ - Jonathan Sharun announces that following: (a) numerous transactions including the last of 95,000 common shares (" Common Shares ") of Top Strike Resources ...
"Vencanna Ventures" (the "Corporation" or "Vencanna") (CSE: VENI; OTCQB: TPPRF) provides the below corporate activity and market update. Vencanna's balance sheet currently consists of cash ($4.15 million as of January 31, 2020), a majority ownership in New Jersey cultivation and dispensary applications (60% ownership in the cultivation application and 54% ownership in the dispensary application, the "New Jersey Applications") and a US$3.3 million convertible note (approximately US$3.8 million outstanding including accrued interest, the "Galenas Note") in Galenas LLC ("Galenas"). The Galenas Note is convertible at the Corporation's option at any time, subject to regulatory approvals, into a 35% equity interest in Galenas, one of only 32 licensed Ohio medical cultivation companies (and one of only 20 currently operating).